Access and Evidence
Decoding the patient journey with RWD
Patient real-world data contains a wealth of potentially valuable information for life sciences commercial teams, if they can filter out the noise
Multichannel
Innovating with the wizards of AI
As the life sciences sector increasingly looks beyond the pill to help drive better outcomes, more pharma companies are looking to develop...
Access and Evidence
Decoding the patient journey with RWD
There’s so much information out there today about what makes consumers tick with significant value for any who care to gather an...
Latest
-
-
Multichannel
Innovating with the wizards of AI
New applications for AI are opening up vast possibilities in healthcare if pharma can collaborate to innovate -
Commercial
Unlocking the full potential of biosimilars
The future looks bright for biosimilars in an age of crisis over healthcare affordability -
Medical
Transforming cancer care through earlier intervention
In our Q&A with Dave Fredrickson, we explore the efforts to continue innovating and bringing better care to cancer patients during and beyond the pandemic -
Access and Evidence
Keeping it real: How data is driving healthcare reform in China
China’s healthcare market is ripe for those capable of helping it capture the vast potential of real-world data
Most Popular
Jill Donahue, (Jun 7, 2021)
Following in his physician father's footsteps, for this pharma leader it's always been about the patient
Andrew Stone, (Jul 7, 2021)
Incubators are starting to prove their worth by enabling pharma to explore new tech and by challenging pharma’s internal culture
Pamela Whitby, (Jul 2, 2021)
The future looks bright for biosimilars in an age of crisis over healthcare affordability
Opinion
Jill Donahue, (Jun 7, 2021)
Following in his physician father's footsteps, for this pharma leader it's always been about the patient
Jill Donahue, (Mar 11, 2021)
This pharma leader worked in a war zone. Now he’s using the same tactics to navigate the pandemic
Commercial
-
Unlocking the full potential of biosimilars
The future looks bright for biosimilars in an age of crisis over healthcare affordability -
Accelerating commercial success in CAGT
To build on the successes thus far in cell and gene therapy, pharma must foster further payer, physician and patient buy-in -
Blended and augmented: Reimagining the role of the rep
The events of 2020 have compelled pharma to reimagine the role of the rep to better adapt to the new rules of engagement -
Uncorking the compliance bottlenecks in digital
The sudden demand for digital content this year has created serious compliance bottlenecks that pharma is racing to overcome with new processes and technology -
Creating a holistic customer experience
Finding solutions to unmet customer needs means harnessing the combined power of medical and marketing skills – and creating a culture to match
Access and Evidence
-
Decoding the patient journey with RWD
Patient real-world data contains a wealth of potentially valuable information for life sciences commercial teams, if they can filter out the noise -
Keeping it real: How data is driving healthcare reform in China
China’s healthcare market is ripe for those capable of helping it capture the vast potential of real-world data -
Including the caregiver in access submissions
Partnering with caregivers can help build a more powerful case for re-imbursement if pharma can gather the right evidence -
A burning desire to make a difference for patients
Annexus Health, eyeforpharma’s 2020 Health Start-up winner is on a mission for patients -
From reactive to predictive: Concerto’s new compositions
Artificial Intelligence has only just begun to unlock high value innovation. The latest predictive tools will break new ground, says Concerto HealthAI’s Jeff Elton
Patients and Medical
-
Optimizing patient Engagement in Trials
The importance of involving the patient at all stages of trials post-pandemic has never been clearer -
Fixing the broken patient search experience
There’s opportunity as well as danger in the billion healthcare searches made every day. Why isn’t pharma tuning in? -
The value in measuring the patient experience
Pharma can improve outcomes, products and HCP relationships using technology to capture patients’ day-to-day experience of their disease -
Better research through patient insights
AstraZeneca’s innovations in chronic kidney disease are pointing the way to new ways of involving patients and RWE to drive new insights and better outcomes -
Building a health equity culture
Health inequities, often a legacy of racism, lie heavy on the healthcare sector in the US and beyond. Fixing the problem will require long-term effort on multiple fronts
Latest Videos
Upcoming Events
View All EventsAugust 2021
-
FREE WEBINAR: Speak to the new wave of patient influencers on social media
Aug 5, 2021 - Aug 5, 2021
-
FREE WEBINAR: Health data interoperability: realise the benefits and mitigate the risks
Aug 5, 2021 - Aug 5, 2021
-
FREE WEBINAR: Health data exchange: A new era of collaboration and interoperability
Aug 12, 2021 - Aug 12, 2021
September 2021
October 2021
-
Pharma 2021 (formerly eyeforpharma Barcelona)
Oct 12, 2021 - Oct 22, 2021
Digital Conference, Exhibition & Networking